P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses

L. Ndhlovu; E. Sinclair; L. Epling; Q. X. Tan; T. Ho; A. R. Jha; J. A. Levy; D. F. Nixon; J. D. Barbour; F. M. Hecht

doi:10.1186/1742-4690-6-S3-P239

P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses

L. Ndhlovu, E. Sinclair, L. Epling, Q. X. Tan, T. Ho, A. R. Jha, J. A. Levy, D. F. Nixon, J. D. Barbour, F. M. Hecht

Biology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Article number	1742
Pages (from-to)	P239
Journal	Retrovirology
Volume	6
Issue number	SUPPL. 3
DOIs	https://doi.org/10.1186/1742-4690-6-S3-P239
State	Published - Oct 22 2009

ASJC Scopus subject areas

Virology
Infectious Diseases

Access to Document

10.1186/1742-4690-6-S3-P239

Cite this

Ndhlovu, L., Sinclair, E., Epling, L., Tan, Q. X., Ho, T., Jha, A. R., Levy, J. A., Nixon, D. F., Barbour, J. D., & Hecht, F. M. (2009). P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses. Retrovirology, 6(SUPPL. 3), P239. Article 1742. https://doi.org/10.1186/1742-4690-6-S3-P239

@article{2e2c1928e43842fc80f28d807b0ec99b,

title = "P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses",

author = "L. Ndhlovu and E. Sinclair and L. Epling and Tan, {Q. X.} and T. Ho and Jha, {A. R.} and Levy, {J. A.} and Nixon, {D. F.} and Barbour, {J. D.} and Hecht, {F. M.}",

year = "2009",

month = oct,

day = "22",

doi = "10.1186/1742-4690-6-S3-P239",

language = "English (US)",

volume = "6",

pages = "P239",

journal = "Retrovirology",

issn = "1742-4690",

publisher = "BioMed Central",

number = "SUPPL. 3",

}

TY - JOUR

T1 - P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses

AU - Ndhlovu, L.

AU - Sinclair, E.

AU - Epling, L.

AU - Tan, Q. X.

AU - Ho, T.

AU - Jha, A. R.

AU - Levy, J. A.

AU - Nixon, D. F.

AU - Barbour, J. D.

AU - Hecht, F. M.

PY - 2009/10/22

Y1 - 2009/10/22

UR - http://www.scopus.com/inward/record.url?scp=70449723193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449723193&partnerID=8YFLogxK

U2 - 10.1186/1742-4690-6-S3-P239

DO - 10.1186/1742-4690-6-S3-P239

M3 - Comment/debate

AN - SCOPUS:70449723193

SN - 1742-4690

VL - 6

SP - P239

JO - Retrovirology

JF - Retrovirology

IS - SUPPL. 3

M1 - 1742

ER -

P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this